2023
DOI: 10.1016/j.abb.2023.109552
|View full text |Cite
|
Sign up to set email alerts
|

XBP1s acts as a transcription factor of IRE1α and promotes proliferation of colon cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 40 publications
0
6
0
Order By: Relevance
“…Numerous studies have pointed out that ERS is not only involved in the development of multiple tumors but can also affect chemoresistance, immune function and invasive metastasis of tumor cells 23–25 . In CRC, when ERS, IRE1α is activated to produce XBP1s by cutting mRNA, while XBP1s acts as a transcription factor binding to IRE1α promoter to transcribe IRE1 α to form an IRE1α‐XBP1s axis to induce cancer cell proliferation 26 . In the process of ERS‐induced epithelial‐mesenchymal transformation (EMT), GRP78/PERK signaling pathway is activated, which promotes nuclear translocation of ATF4 and increases the transcriptional activity of interleukin‐like met inducers, which accelerates tumor progression 27 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Numerous studies have pointed out that ERS is not only involved in the development of multiple tumors but can also affect chemoresistance, immune function and invasive metastasis of tumor cells 23–25 . In CRC, when ERS, IRE1α is activated to produce XBP1s by cutting mRNA, while XBP1s acts as a transcription factor binding to IRE1α promoter to transcribe IRE1 α to form an IRE1α‐XBP1s axis to induce cancer cell proliferation 26 . In the process of ERS‐induced epithelial‐mesenchymal transformation (EMT), GRP78/PERK signaling pathway is activated, which promotes nuclear translocation of ATF4 and increases the transcriptional activity of interleukin‐like met inducers, which accelerates tumor progression 27 .…”
Section: Discussionmentioning
confidence: 99%
“… 23 , 24 , 25 In CRC, when ERS, IRE1α is activated to produce XBP1s by cutting mRNA, while XBP1s acts as a transcription factor binding to IRE1α promoter to transcribe IRE1 α to form an IRE1α‐XBP1s axis to induce cancer cell proliferation. 26 In the process of ERS‐induced epithelial‐mesenchymal transformation (EMT), GRP78/PERK signaling pathway is activated, which promotes nuclear translocation of ATF4 and increases the transcriptional activity of interleukin‐like met inducers, which accelerates tumor progression. 27 In pancreatic cancer, activation of ERS induces the epithelial‐mesenchymal transition, which exacerbates tumor cell invasion and metastasis and contributes to accelerated tumor progression.…”
Section: Discussionmentioning
confidence: 99%
“…These facts clearly demonstrate that neoplastic cells can acquire the ability to self-select, allowing them to survive in unfavourable environments [35][36]. The positive modulation of IRE1α induces the expression of XBP1, XBP1s and ERAD, further facilitating the survival of the malignant cell [21,37]. PERK activation via ARE, Keap1 and ATF4 may also favour the survival of neoplastic cells in hostile environments with nutrient deficiency, ATP shortage, ROS production and hypoxia [4,38].…”
Section: Antagonistic Mechanisms Observed By Upr Activation By the Erementioning
confidence: 95%
“…Yet, XBP1 is a biomarker of CRC invasion and metastasis, and its expression accelerates cancer cell invasion, suppressed by knockout of XBP1 using small interfering RNA (siRNA). When XBP1s is silenced, VEGF receptor 2 (VEGF-R2) levels, recognized as inducers of tumour angiogenesis, are drastically reduced [37,51]. XBP1s inhibits the expression of the tumour suppressor TAp73, a member of the p53 protein family, by binding directly to the TAp73 promoter and suppressing its transcriptional activity.…”
Section: Ire1α As a Protagonist In The Angiogenesis Of Crc Developmentmentioning
confidence: 99%
See 1 more Smart Citation